Skip to main content
Quest Diagnostics

Biomarkers of Glucose-Insulin Homeostasis, Randomized Treatment With Omega-3 and Vitamin D Supplementation, and Incident Type 2 Diabetes: Prospective Analysis From the VITamin D and OmegA-3 TriaL (VITAL)

AHA 2021: Scientific Sessions if the American Heart Association
Nashville, TN, November 13-15, 2021

Biomarkers of Glucose-Insulin Homeostasis, Randomized Treatment With Omega-3 and Vitamin D Supplementation, and Incident Type 2 Diabetes: Prospective Analysis From the VITamin D and OmegA-3 TriaL (VITAL)

Authors: Qian F,  Guo Y, Luttmann-Gibson H, Gomelskaya N, Liu Y ,  Demler O, Cook N, Lee I-M, Buring JE, Larsen J, Boring J, McPhaul MJ, Manson JE,  Pradhan A, Mora S

Specialties: cardiovascular disease, endocrinology

Download key summary

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA certified laboratories that provide HIPAA covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2024 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only.